Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury
Alfredo Gorio(University of Milan), Michael Brines(Northwell Health), Anthony Cerami(Araim Pharmaceuticals (United States)), Stephana Carelli(ASST Fatebenefratelli Sacco), Anna Barbara Di Stefano(University of Milan), Thomas R. Coleman(University of Messina), Laura Madaschi(University of Milan), Silvia De Biasi(University of Milan), Anna Maria Di Giulio(University of Milan)
Cited by 130
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654